Logo for Athira Pharma Inc

Athira Pharma Investor Relations Material

Latest events

Logo for Athira Pharma Inc

Virtual R&D Event 2022

Athira Pharma
Logo for Athira Pharma

Q4 2023

22 Feb, 2024
Logo for Athira Pharma

Q3 2023

9 Nov, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Athira Pharma Inc

Access all reports
Athira Pharma Inc., also known as Athira Pharma, is a late clinical-stage biopharmaceutical company focused on developing small molecules aimed at restoring neuronal health and slowing neurodegeneration. The company's leading product candidate, ATH-1017 (Fosgonimeton), is designed to enhance the activity of the hepatocyte growth factor (HGF) and its receptor, MET. The company is headquartered in Bothell, Washington, and its shares are listed on the NASDAQ.